Procainamide Hydrochloride Injection
Product Images NDC 14789-900

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Procainamide Hydrochloride (NDC 14789-900). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nexus Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Pra Structure)

Chemical structure of Procainamide Hydrochloride illustrating its molecular formula with the aromatic ring, amide group, and alkylamine substituents. The structure includes the hydrochloride (HCl) component and indicates a molecular weight of 271.79.*

FDA Label Image

Principal Display Panel (2 mL Carton Label)

The packaging label for Procainamide HCL Injection, USP, 1,000 mg/2 mL (500 mg/mL) by Nexus Pharmaceuticals LLC. The label specifies the product is for intramuscular or intravenous use and contains 10 x 2 mL multiple-dose vials. It includes a warning about the presence of metabisulfite and instructions for storage at 20-25°C. The label also notes the product is sterile, nonpyrogenic, preservative-added, and free from natural rubber latex in the container closure.*

FDA Label Image

Principal Display Panel (2 mL Vial Label)

Label for Procainamide HCL Injection, USP 500 mg/mL in a 2 mL multiple-dose vial. Includes active ingredient details, preservatives, usage warnings, storage instructions, and manufacturer Nexus Pharmaceuticals, LLC. The label is for an injectable dosage form intended for intramuscular or intravenous use.*

FDA Label Image

Principal Display Panel (10 mL Carton Label)

Procainamide Hydrochloride Injection USP 1,000 mg/10 mL (100 mg/mL) multiple-dose vial packaging label by Nexus Pharmaceuticals LLC. The label indicates intramuscular and intravenous use, contains a warning about metabisulfite, and states storage instructions. The product is manufactured in Italy for Nexus Pharmaceuticals, Lincolnshire, IL.*

FDA Label Image

Principal Display Panel (10 mL Vial Label)

Procainamide Hydrochloride Injection, USP 100 mg/mL in a 10 mL multiple-dose vial. The label indicates the product is manufactured in Italy for Nexus Pharmaceuticals LLC, Lincolnshire, IL. It includes preservation ingredients, storage instructions at 20° to 25°C, and warnings about discoloration and metabistulfite content. Barcode and blank expiration and lot fields are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.